Navigation Links
ePharmaSolutions Announces the Deployment of its Enterprise Clinical Trial Portal for Two Global Biopharmaceutical Companies
Date:8/24/2011

CONSHOHOCKEN, Pa., Aug. 24, 2011 /PRNewswire/ -- ePharmaSolutions announced the successful deployment of its Enterprise level Clinical Trial Portal (CTP) for a top five global pharmaceutical company on more than 900 studies to 90 countries and a second client deployment scheduled for September 2011.

Clinical Trial Portals help streamline and accelerate the clinical development process for sponsors, study sites and third party vendors by providing a common technology platform from which to conduct their trials.  Historically these portals were deployed at the study level, resulting in measurable improvements in time and cost for that study.  Today, biopharmaceutical companies are standardizing on single vendors to provide these portal solutions across the enterprise to help realize the time and cost savings across the enterprise while simplifying the process for study teams and site users.

"We are seeing more of our sponsors and CRO partners migrate from single study workspaces to enterprise CTP deployments this year than ever," stated Lance Converse, ePharmaSolutions' Founder and CEO.  "Enterprise deployments of the CTP help force the standardization of business processes across the clinical development lifecycle while reducing cost and accelerating timelines," added Converse.

ePharmaSolutions' Clinical Trial Portal is currently used by more than 235,000 users in 120 countries and helps biopharmaceutical companies improve and accelerate site activation, study training, safety letter distribution, and patient recruitment while integrating all of the third-party vendor applications (EDC, IXRS, Labs, etc.) to help centralize study management/reporting and provide users with one website and one set of credentials for all of their clinical study needs.

"Enterprise deployments typically include integrations with the clients' CTMS, EDC and IXRS systems, which can significantly reduce the amount of data entry required across the various systems used to conduct trials in today's technology driven clinical trials environment," stated Steven Beales, ePharmaSolutions Vice President of Information Technology.  "The integrations allow the study teams to add or edit a user in the CTP and authenticate that change to all of the systems used in the study, eliminating redundant manual data entry and multiple account registrations forms," Beales added.

The typical cost saving for using the Clinical Trial Portal on a one year 75 site global oncology study can exceed $1 million dollars (US) when compared to the traditional cost of paper based site feasibility, study document completion, in-person training and overnighted safety letter distribution.

About ePharmaSolutions

ePharmaSolutions is a leading provider of technology-based clinical services that helps improve the way sites are selected, trained, activated and managed to exceed enrollment goals.   ePharmaSolutions won the 2009 Bio-IT World Award for best clinical trial technology and has activated and trained more than 235,000 clinical researchers in 120 countries for the top 20 pharmaceutical companies in the world.  ePharmaSolutions is headquartered in Philadelphia with offices in London. For more information visit www.epharmasolutions.com or call Lance Converse at 610-832-9915.  Follow us on LinkedIn and Facebook.


'/>"/>
SOURCE ePharmaSolutions
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ePharmaSolutions Clinical Trial Investigator Portal Wins Bio-IT World 2009 Best Practice Award
2. ePharmaSolutions Launches New Version of Electronic Monitor Visit Report Application With Industry-Leading Online and Offline Capabilities
3. ePharmaSolutions Launches Major Release of Its Global Safety Letter Distribution and Tracking Application in More Than 90 Countries
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... N.Y. , Feb. 5, 2016  Henry Schein, ... health care products and services to office-based dental, animal ... entered into an agreement to acquire a majority ownership ... supplies and equipment in Brazil . ... Headquartered in Blumenau, Brazil, Dental Cremer is the dental distribution ...
(Date:2/4/2016)... For hospitals considering enrollment in the Federal ... the program, the Health Resources and Services Administration,s (HRSA) ... Mega-Guidance , could have significant impact on plans and ... 2016. Essential Insights , Daniel Neal, ... the Mega-Guidance,s key proposed changes, including a new requirement ...
(Date:2/4/2016)... 4, 2016   Bernstein Liebhard LLP today announced ... United States District Court for the District of ... consisting of all persons or entities who purchased common shares ... INSY ) from March 3, 2015 through January 25, 2016 ... its officers with violations of the Securities Exchange Act of ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... 05, 2016 , ... US Sports Camps , official operators of Nike ... high-performance kids yoga training. ChildLight Yoga Studio is centrally situated in the picturesque New ... ChildLight Yoga Studio founder Lisa Flynn expresses her excitement, “We are thrilled to be ...
(Date:2/5/2016)... ... , ... Give To Cure today announced that it is working ... To Cure’s campaign that is crowdfunding clinical trials to help find cures faster for ... a smart device. In 2015 alone, Venmo processed $7.5 billion in transactions among users. ...
(Date:2/5/2016)... ... ... Dr. Justin Scott and Dr. Lydia Muccioli of Pure Dental Health ... in need. The event is scheduled to take place on February 27, 2016 from ... dental care to community members in need. Each patient will be given the opportunity ...
(Date:2/5/2016)... ... February 05, 2016 , ... In sleep, when the defenses of ... A hallmark feature of patients with eating disorders is significant self-criticism, and consequently these ... and obsessions are regarded as maladaptive means for coping with this unease, but also ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Calls Blacklist has ... completely new user interface design and the developer has fixed known bugs within the ... want to on their phone while not consuming any of their device’s battery power ...
Breaking Medicine News(10 mins):